Location History:
- Shizuoka-ken, JP (1999)
- Shizuoka, JP (1994 - 2014)
- Gotenba, JP (1999 - 2015)
Company Filing History:
8 out of 949 
1 out of 9 
1 out of 12 
Years Active: 1994-2015
Title: Masahiko Mihara: Innovator in Medical Treatments
Introduction
Masahiko Mihara is a prominent inventor based in Gotenba, Japan. He has made significant contributions to the field of medical treatments, particularly in the area of diseases mediated by sensitized T cells. With a total of 8 patents to his name, Mihara's work has the potential to impact therapeutic strategies significantly.
Latest Patents
Mihara's latest patents include innovative methods for treating diseases mediated by sensitized T cells. One notable patent involves a preventive or therapeutic agent for sensitized T cell-mediated diseases, which comprises an interleukin-6 (IL-6) antagonist. This includes antibodies directed against the IL-6 receptor, IL-6 itself, and gp130. Another significant patent focuses on methods for suppressing acute rejection of heart transplants. This research demonstrated that anti-IL-6 receptor antibodies could significantly reduce cytotoxic T cell induction, leading to prolonged survival of transplanted hearts in mouse models.
Career Highlights
Throughout his career, Mihara has worked with notable companies such as Chugai Pharmaceutical Co., Ltd. and Tadamitsu Kishimoto. His research has been pivotal in advancing our understanding of immune responses and transplant rejection.
Collaborations
Mihara has collaborated with esteemed colleagues, including Yoichiro Moriya and Yoshiyuki Ohsugi. These partnerships have further enriched his research and contributed to the development of innovative medical treatments.
Conclusion
Masahiko Mihara's contributions to medical science through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in treating diseases and improving transplant outcomes.